These findings may thus provide insight into a potential gut microbiome-derived mechanism that could contribute to the understanding as to why there is a 78% reduction in the incidence of PD among IBD patients who had taken anti-TNF therapies as reported by Peter et al.20. Here, TNF is linked to inflammatory bowel disease.